Investors & Media
VYNE Therapeutics™ is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
1.92
Mar. 18, 2024 16:00:00- Change -0.09 (-4.4776%)
- Volume 74,132
- Today's Open 2.01
- Previous Close 2.01
- Today's High 2.0243
- Today's Low 1.92
- 52 Week High 8.73
- 52 Week Low 1.67